Prognostic significance of erythropoietin expression in human endometrial carcinoma (Q44908381)

7 December 2017

Prognostic significance of erythropoietin expression in human endometrial carcinoma (English)

1 reference

7 December 2017

1 reference

Geza Acs

1

1 reference

7 December 2017

Xiaowei Xu

2

1 reference

7 December 2017

Christina Chu

3

1 reference

7 December 2017

Peter Acs

4

1 reference

7 December 2017

Ajay Verma

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

7 December 2017

100

1 reference

7 December 2017

11

1 reference

7 December 2017

2376-2386

1 reference

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

7 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

Ovarian steroid and cytokine modulation of human endometrial angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

Erythropoietin and erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Signal transduction in the erythropoietin receptor system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Origin and fate of erythropoietin in human milk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Erythropoietin and erythropoietin receptor in the developing human central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20244

7 January 2021

Identifiers

DOI

10.1002/CNCR.20244

1 reference

7 December 2017

1 reference